TL;DR
- •Nurses have elevated suicide and depression rates compared to the general population — recent epidemiological analyses (Kreuze 2025) identify nurses as a high-risk occupational group, with female nurses showing suicide rates substantially above age-matched non-nurses.
- •12-hour shifts, secondary trauma exposure, moral injury from staffing shortages, and the COVID-era legacy of patient deaths produce a chronic-stress profile that's often not fully resolved by time off or therapy alone.
- •Telehealth ketamine therapy fits nursing schedules — sessions between shifts, no clinic visits, completely private from hospital systems and nurse-licensure databases.
- •Tovani is direct-pay ($349/month, HSA/FSA eligible) — bypasses hospital benefits records. For licensure and DEA-registration concerns, see privacy section below.
- •For treatment-resistant depression where multiple SSRIs and therapy haven't produced enough response, ketamine's NMDA/glutamate mechanism is a meaningfully different approach with rapid onset.
- •Most nurse-patients say what mattered most was: another clinician understanding shift work and trauma exposure; same physician every visit; clear answer on board and DEA implications; complete separation from hospital records.
The stressors specific to your work
- •Secondary trauma from sustained patient-death and crisis exposure
- •12-hour shifts disrupting sleep, exercise, and recovery time
- •Moral injury from staffing shortages — knowing what good care looks like but unable to deliver it
- •Workplace violence (verbal and physical) directed at nursing staff at elevated rates
- •COVID-era legacy of repeated mass-casualty events still unprocessed for many
- •Board-disclosure and DEA-registration anxiety suppressing help-seeking
Why telehealth works for nurses
- •No clinic visits — fits between shifts and post-night rotations
- •Sessions scheduled on days off, no need to take PTO
- •Treatment in your own home — completely private from coworkers and management
- •Same physician every visit — continuity matters when shift schedules disrupt routine
- •Completely separate from hospital EAP, employer health plan, or licensing-board databases
Privacy considerations
- •Tovani is direct-pay — no insurance claim is filed unless you submit for reimbursement yourself.
- •Patient records are HIPAA-protected and never shared with hospitals, state boards of nursing, DEA, or any employer or regulatory body without your explicit written authorization.
- •State nursing board disclosure rules vary, but most jurisdictions only require disclosure of conditions that impair fitness to practice, not the existence of outpatient treatment itself. Routine, well-managed depression or anxiety treatment is generally not reportable.
- •For nurses with DEA registration (most APRNs and some specialty RNs), routine outpatient mental-health treatment that does not involve impaired-practice or controlled-substance misuse is generally not a DEA-reportable event — but if you have specific concerns, consult a nurse-attorney or your state's peer-assistance program (most states have confidential nurse-assistance programs separate from disciplinary processes).
DEA / licensure-sensitive role
Your profession has specific board-disclosure considerations. Discuss with your physician during consultation. For state-specific guidance, contact your state’s professional-assistance program.
5-minute screening · Reviewed by a board-certified physician · FL & NJ · $349/month
Frequently asked
Will my state board of nursing find out?
No — not from Tovani. We don't report routine outpatient mental-health treatment to any state board or licensing database. Most state nursing-board disclosure questions ask about conditions that impair fitness to practice, NOT about whether you've ever received mental-health treatment. Well-managed outpatient depression or anxiety treatment is typically not reportable. If you have specific concerns, your state's confidential nurse-assistance program is a non-disciplinary resource — call them before disclosing anything to the board itself.
I have DEA registration as an APRN. Does ketamine treatment affect that?
Routine outpatient mental-health treatment that doesn't involve impaired-practice events or controlled-substance misuse is not a DEA-reportable event for registered prescribers. The DEA cares about your ability to securely handle controlled substances and prescribe responsibly — receiving treatment for depression doesn't affect either. If you have specific concerns or there's a complicating factor (past DEA action, hospital credentialing issue), consult a healthcare attorney before starting.
I work night shifts. Can I do ketamine therapy while doing nights?
Yes, with planning. Sessions are scheduled on your days off, not before a shift. Avoid scheduling within 24 hours of a clinical shift. Many night-shift nurses do sessions on the first full day after a rotation block and before the next one begins. Your physician helps work it around your schedule.
I've tried SSRIs and therapy and the moral injury / burnout hasn't lifted. What now?
When standard approaches produce only partial response, options include mechanism-switching (NDRI, SNRI, ketamine), augmentation strategies, TMS, or — for the specific subset where the pattern is treatment-resistant depression with chronic occupational trauma — ketamine combined with trauma-focused therapy. The "neuroplasticity window" effect after ketamine sessions may enhance trauma-processing therapy work.
Can I do this without my manager / charge nurse / coworkers knowing?
Yes. Tovani is HIPAA-protected, direct-pay (no insurance claim visible to your employer), and never shares information with hospitals, healthcare systems, or coworkers without your explicit written authorization. Sessions happen in your home — no clinic where coworkers might see you. Many nurse-patients keep this entirely separate from their professional environment.
References
- Kreuze E et al. 2025, Journal of Nursing Scholarship. Global examination of nurse suicide epidemiology and cohort data — establishes elevated suicide risk and the need for treatment access models that account for licensure and stigma barriers. PMID 40110987
- Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT showed 64% response in treatment-resistant depression — relevant for high-prevalence professions like nursing where prior antidepressant trials are common. PMID 23982301
- Sanacora G et al. 2017, JAMA Psychiatry. APA consensus on ketamine's rapid antidepressant effects in clinical contexts requiring faster response than SSRIs typically provide. PMID 28249076